Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?

File(s)

Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma.pdf (987.42 KB)

Accepted version

Show more

Author(s)

Liu, Daniel SK

Prado, Mireia Mato

Giovannetti, Elisa

Jiao, Long R

Krell, Jonathan

more

Type

Journal Article

Date Issued

2019-06-10

Date Acceptance

2019-05-20

Citation

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare, 2019, 19 (7), pp.553-558

URI

http://hdl.handle.net/10044/1/75045

DOI

https://www.dx.doi.org/10.1080/14737159.2019.1622414

ISSN

1473-7159

Publisher

Taylor & Francis

Start Page

553

End Page

558

Journal / Book Title

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

Volume

19

Issue

7

Copyright Statement

© 2019 Informa UK Limited, trading as Taylor & Francis Group. This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Molecular Diagnostics on 10 Jun 2019, available online: https://www.tandfonline.com/doi/full/10.1080/14737159.2019.1622414

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000472255800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Pathology

Circulating tumor DNA (ctDNA)

exosomes

KRAS

survival

biomarker

pancreatic ductal adenocarcinoma

PDAC

MUTANT KRAS

DNA

CANCER

DIAGNOSIS

CELLS

Publication Status

Published

Date Publish Online

2019-06-10